Use of angiotensin-converting enzyme inhibitors for Alzheimer’s disease: an update

By O’Caoimh Rónán   Kehoe Patrick Gavin   Kennedy Paul   Molloy William  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 511-514

Future Medicine

Access to resources Recommend Favorite

Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients

By Camelo D.   Arboleda G.   Yunis J.J.   Pardo R.   Arango G.   Solano E.   Lopez L.   Hedmont D.   Arboleda H.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Prior use of angiotensin-converting enzyme inhibitors does not affect outcome in patients with intracerebral hemorrhage

By Eichel Roni   Khouri Salim T.   Cohen Jose E.   Ben-Hur Tamir   Paniri Ruth   Keidar Michal   Leker Ronen R.  

Neurological Research, Vol. 32, Iss. 9, 2010-11 ,pp. : 905-909

Maney Publishing

Access to resources Recommend Favorite

Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer’s disease and vascular dementia

By Wang H. K.   Fung H. C.   Hsu W. C.   Wu Y. R.   Lin J. C.   Ro L. S.   Chang K. H.   Hwu F. J.   Hsu Y.   Huang S. Y.   Lee-Chen G. J.   Chen C. M.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1499-1509

Springer Publishing Company

Access to resources Recommend Favorite

The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE ε4 allele increases the risk of late-onset Alzheimer disease

By Wang Binbin   Jin Feng   Yang Ze   Lu Zeping   Kan Rui   Li Shu   Zheng Chenguang   Wang Li  

Journal of Molecular Neuroscience, Vol. 30, Iss. 3, 2006-10 ,pp. : 267-271

Humana Press, Inc

Access to resources Recommend Favorite